1FX — Ananda Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- €2.15m
- €2.36m
- £0.00m
Annual cashflow statement for Ananda Pharma, fiscal year end - January 31st, millions except per share.
2021 January 31st | 2022 January 31st | 2023 January 31st | 2024 January 31st | 2025 January 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ||
| Standards: | — | — | IFRS | IFRS | IFRS |
| Status: | fx Preliminary | fx Preliminary | Final | Final | Final |
| Net Income/Starting Line | — | — | -1.14 | -6.14 | -3.66 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | — | — | 0.309 | -0.729 | 1.4 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | — | — | 0.201 | 1.09 | 0.816 |
| Change in Accounts Receivable | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | — | — | -0.457 | -0.722 | -0.816 |
| Capital Expenditures | — | — | — | -0.003 | 0 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | -1.45 | 0.024 | 0.02 |
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | — | — | -1.45 | 0.021 | 0.02 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | — | — | 1.92 | 0.766 | 2.38 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | — | — | 0.019 | 0.066 | 1.58 |